Trazodone/Gabapentin

曲唑酮/加巴喷丁

Report date: 2025/06/06 20:01:13

Base Information

Drug NameTrazodone/Gabapentin
Drug Alias Name加巴喷丁+曲唑酮Trazodone hydrochloride/gabapentin FDCTrazodone hydrochloride+gabapentin FDC曲唑酮+加巴喷丁加巴喷丁/曲唑酮 +[8] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 2 blockersSerotonin transporter inhibitorsVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunitVoltage-gated calcium channel alpha2/delta subunit 2Serotonin transporter
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPolandUnited Kingdom +[4] 
CombinationsYes Trazodone HydrochlorideGabapentin
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Group
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAziende Chimiche Riunite Angelini Francesco Spa
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A